Pfizer has named Cathy Pachuk as senior director of delivery technology at its Research Technology Center, which focuses on RNAi therapeutics efforts among other areas. The company has also appointed C. Satishchandran as chief technology officer of the RTC. Both Pachuk and Satishchandran were co-founders of Nucleonics, a now-defunct developer of expressed RNAi-based drugs.